Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Invested Capital (2016 - 2025)

Historic Invested Capital for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $238.9 million.

  • Mimedx's Invested Capital rose 2995.52% to $238.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.9 million, marking a year-over-year increase of 2995.52%. This contributed to the annual value of $212.1 million for FY2024, which is 1006.14% up from last year.
  • According to the latest figures from Q3 2025, Mimedx's Invested Capital is $238.9 million, which was up 2995.52% from $217.9 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Invested Capital peaked at $238.9 million during Q3 2025, and registered a low of $29.0 million during Q3 2022.
  • For the 5-year period, Mimedx's Invested Capital averaged around $105.6 million, with its median value being $48.2 million (2021).
  • Per our database at Business Quant, Mimedx's Invested Capital tumbled by 5908.49% in 2021 and then skyrocketed by 52967.07% in 2023.
  • Over the past 5 years, Mimedx's Invested Capital (Quarter) stood at $48.2 million in 2021, then tumbled by 36.51% to $30.6 million in 2022, then soared by 529.67% to $192.7 million in 2023, then rose by 10.06% to $212.1 million in 2024, then increased by 12.65% to $238.9 million in 2025.
  • Its Invested Capital was $238.9 million in Q3 2025, compared to $217.9 million in Q2 2025 and $203.9 million in Q1 2025.